These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26099560)

  • 21. Lessons learned from stakeholder-driven sustainability analysis of six national HIV programmes.
    Katz I; Glandon D; Wong W; Kargbo B; Ombam R; Singh S; Ramsammy L; Tal-Dia A; Seck I; Osika JS
    Health Policy Plan; 2014 May; 29(3):379-87. PubMed ID: 23612848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large-scale initiative to disseminate an evidence-based drug abuse prevention program in Italy: Lessons learned for practitioners and researchers.
    Velasco V; Griffin KW; Antichi M; Celata C
    Eval Program Plann; 2015 Oct; 52():27-38. PubMed ID: 25913236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving scale rapidly in public health: Applying business management principles to scale up an HIV prevention program in India.
    Sgaier SK; Ramakrishnan A; Wadhwani A; Bhalla A; Menon H; Baer J; Alexander A
    Healthc (Amst); 2018 Sep; 6(3):210-217. PubMed ID: 28943225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach.
    Boily MC; Lowndes CM; Vickerman P; Kumaranayake L; Blanchard J; Moses S; Ramesh BM; Pickles M; Watts C; Washington R; Reza-Paul S; Labbe AC; Anderson RM; Deering KN; Alary M;
    Sex Transm Infect; 2007 Dec; 83(7):582-9. PubMed ID: 17942574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007.
    Cáceres CF; Girón JM; Sandoval C; López R; Valverde R; Pajuelo J; Vásquez P; Rosasco AM; Chirinos A; Silva-Santisteban A
    Glob Public Health; 2010; 5(3):247-65. PubMed ID: 20390630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring and Evaluating the Transition of Large-Scale Programs in Global Health.
    Bao J; Rodriguez DC; Paina L; Ozawa S; Bennett S
    Glob Health Sci Pract; 2015 Dec; 3(4):591-605. PubMed ID: 26681706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The results framework--an innovative tool for program planning and evaluation.
    Toffolon-Weiss MM; Bertrand JT; Terrell SS
    Eval Rev; 1999 Jun; 23(3):336-59. PubMed ID: 10538787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fighting tuberculosis and HIV/AIDS in Northeast Europe: sustainable collaboration or political rhetoric?
    Rowe L; Rechel B
    Eur J Public Health; 2006 Dec; 16(6):609-14. PubMed ID: 16641160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Domestic Funding Enhances the Sustainability of HIV/AIDS Response in Nigeria.
    Olakunde BO; Ndukwe CD
    Ann Glob Health; 2015; 81(5):684-8. PubMed ID: 27036726
    [No Abstract]   [Full Text] [Related]  

  • 30. Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.
    Kelley KF; Caudwell E; Xueref S; Ha TH; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4():S250-3. PubMed ID: 22544183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical and effective ALARA.
    Bevelacqua JJ
    Health Phys; 2010 May; 98 Suppl 2():S39-47. PubMed ID: 20386191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community interventions providing care and support to orphans and vulnerable children: a review of evaluation evidence.
    Schenk KD
    AIDS Care; 2009 Jul; 21(7):918-42. PubMed ID: 20024749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Program Evaluation and Monitoring System: a key source of data for monitoring evidence-based HIV prevention program processes and outcomes.
    Thomas CW; Smith BD; Wright-DeAgüero L
    AIDS Educ Prev; 2006 Aug; 18(4 Suppl A):74-80. PubMed ID: 16987090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining sustainability outcomes of health programs: Illustrations from an on-line survey.
    Scheirer MA; Hartling G; Hagerman D
    Eval Program Plann; 2008 Nov; 31(4):335-46. PubMed ID: 18835642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring and evaluation under the PRSP: solid rock or quicksand?
    Holvoet N; Renard R
    Eval Program Plann; 2007 Feb; 30(1):66-81. PubMed ID: 17689314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phoenix Rising: use of a participatory approach to evaluate a federally funded HIV, hepatitis and substance abuse prevention program.
    Dryden E; Hyde J; Livny A; Tula M
    Eval Program Plann; 2010 Nov; 33(4):386-93. PubMed ID: 20233628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovative Methods for Designing Actionable Program Evaluation.
    Nesbit B; Hertz M; Thigpen S; Castellanos T; Brown M; Porter J; Williams A
    J Public Health Manag Pract; 2018; 24 Suppl 1 Suppl, Injury and Violence Prevention(Suppl 1 INJURY AND VIOLENCE PREVENTION):S12-S22. PubMed ID: 29189500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Implementation Research Approach to Evaluating Health Insurance Programs: Insights from India.
    Rao KD; Nagulapalli S; Arora R; Madhavi M; Andersson E; Ingabire MG
    Int J Health Policy Manag; 2016 Mar; 5(5):295-9. PubMed ID: 27239878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.